SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (BSGM) on March 30, 2021. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific corporate event rather than financial performance data.
Material Changes
On March 30, 2021, the U.S. Patent Office allowed a utility patent application (No. 17/082,564) covering the company's Pure EP noise-filtering technology. The application, titled "Systems and Methods for Performing Electrophysiology (EP) Signal Processing," was originally filed on October 28, 2020.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the general context of the patent allowance. The primary disclosure is the successful progression of the intellectual property portfolio.
Investor Verification Checklist
- Verify the full text of the press release filed as Exhibit 99.1 for details on the patent's commercial implications.
- Confirm the status of the patent issuance and any associated legal fees or maintenance costs.
- Review subsequent filings for any impact of this patent on the company's product roadmap or competitive positioning.
- Check the company's latest 10-Q or 10-K for the most recent financial metrics, as this 8-K does not include them.